SV Atlas
← All founders
Alla Arzumanyan

Alla Arzumanyan

CDO @ SFA Therapeutics, Associate Professor @ Temple University

Co-founderSFA Therapeutics logoSFA Therapeutics· Summer 2021Greater Philadelphia
in LinkedIn
2023Biotech Advisor· SmartGateVC
Founder · since 2017
Company
SmartGateVC
Role
Biotech Advisor
current
Stage
—
no public source
Raised
—
no public source
Based
Philadelphia, Pennsylvania, United States
current
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work history
Profile coverage5 of 7 · missing posts, contact
SFA Therapeutics logo
SFA Therapeutics

Regulating the immune system to block cancer & autoimmune diseases

Summer 2021

Experience

Career

  • SFA Therapeutics logo

    SFA Therapeutics

    Co-founder

    Chief Development Officer, Co-founder & Co-inventor · Greater Philadelphia · 2017 – Present

    2017
  • Temple University logo

    Temple University

    Associate Professor · Philadelphia, Pennsylvania, United States · 2023 – Present

    2023
  • Temple University logo

    Temple University

    Manager of the BSL3 Facility · Philadelphia, Pennsylvania, United States · 2020 – Present

    2020
  • Temple University logo

    Temple University

    Assistant Professor · 2011 – 2023

    2011
  • SmartGateVC logo

    SmartGateVC

    Biotech Advisor · Philadelphia, Pennsylvania, United States · 2023 – Present

    2023
  • Thomas Jefferson University logo

    Thomas Jefferson University

    Adjunct Professor · 2018 – 2020

    2018
  • Temple University logo

    Temple University

    Senior Research Scientist, Department of Biology · Greater Philadelphia · 2008 – 2010

    2008
  • Thomas Jefferson University logo

    Thomas Jefferson University

    Postdoctoral Fellow, Department of Pathology, Anatomy, & Cell Biology · Greater Philadelphia · 2005 – 2008

    2005
  • Temple University logo

    Temple University

    Postdoctoral Fellow, Center for Neurovirology, School of Medicine · Greater Philadelphia · 2004 – 2005

    2004

Bio

MS is Microbiology, PhD in Biotechnology, Assistant Professor at Temple University, Co-Founder and Co-Inventor at SFA Therapeutics, Inc. Performed a case-control, Proof-of-Activity Human study to evaluate treatment effect of SFA002 drug (proprietary of SFA Therapeutics, Inc.) on patients with plaque psoriasis. Worked with Axella Research on pre-IND application for SFA002. Worked with HEC (Sunshine Lake Pharma Co., China), Theravectys, and ThirdLaw LLC (still collaborating with the latter)